Article Information
- May 28, 2023.
Article Versions
- You are currently viewing Version 1 of this article (May 28, 2023 - 20:54).
- View Version 2, the most recent version of this article.
Author Information
- Annelien Morlion1,2,
- Philippe Decruyenaere1,2,3,
- Kathleen Schoofs1,2,4,
- Jasper Anckaert1,2,
- Justine Nuytens1,2,
- Eveline Vanden Eynde1,2,
- Kimberly Verniers1,2,
- Celine Everaert4,
- Fritz Offner3,
- Jo Van Dorpe5,
- Jo Vandesompele°,1,2 and
- Pieter Mestdagh*,°,1,2
- 1Department of Biomolecular Medicine, Ghent University, Ghent, Belgium
- 2OncoRNALab, Cancer Research Institute Ghent (CRIG), Ghent, Belgium
- 3Department of Hematology, Ghent University Hospital, Ghent, Belgium
- 4TOBI Lab, Center for Medical Biotechnology, VIB-UGent, Zwijnaarde, Belgium
- 5Department of Pathology, Ghent University Hospital, Ghent, Belgium
- ↵*Corresponding author pieter.mestdagh{at}ugent.be
↵° Both authors contributed equally to this work
Author contributions: Conceptualization: AM, CE, JV, PM Data Curation: AM
Funding acquisition: AM, JV, JVD, PM Software: AM, JA
Validation: AM Formal analysis: AM
Investigation: EV, JN, KV Methodology: AM, JV, PM
Project administration: AM, JV, PM Resources: FO, JV, JVD, KS, PD, PM
Supervision: JV, PM Visualization: AM
Writing – original draft: AM, JV, PM Writing – review & editing: all authors